VTACH trial

Comment

Yujiro Kida. Lancet. 2010.

. 2010 Mar 13;375(9718):890; author reply 890-1.

doi: 10.1016/S0140-6736(10)60380-7.

No abstract available

Comment on

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS; VTACH study group. Kuck KH, et al. Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4. Lancet. 2010. PMID: 20109864 Clinical Trial.

Catheter ablation in patients with ICDs.
Coceani M. Coceani M. N Engl J Med. 2008 May 22;358(21):2295-6. N Engl J Med. 2008. PMID: 18504829 No abstract available.
Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH. Kuck KH. Circ Arrhythm Electrophysiol. 2009 Dec;2(6):713-20; discussion 720. doi: 10.1161/CIRCEP.109.896571. Circ Arrhythm Electrophysiol. 2009. PMID: 20009082 No abstract available.
Treatment approaches for patients with sustained VT/VF.
Mitchell LB, Roy D. Mitchell LB, et al. Can J Cardiol. 2000 Jun;16 Suppl C:23C-5C. Can J Cardiol. 2000. PMID: 10887274 Review. No abstract available.
[Contemporary methods of treatment for ventricular arrhythmias].
Lelakowski J, Majewski J, Małecka B, Bednarek J, Dreher A. Lelakowski J, et al. Pol Merkur Lekarski. 2005 Jul;19(109):102-7. Pol Merkur Lekarski. 2005. PMID: 16194040 Review. Polish.
Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
Patel C, Yan GX, Kocovic D, Kowey PR. Patel C, et al. Circ Arrhythm Electrophysiol. 2009 Dec;2(6):705-11; discussion 712. doi: 10.1161/CIRCEP.109.893628. Circ Arrhythm Electrophysiol. 2009. PMID: 20009081 No abstract available.